Portfolio (Quarterly)
Guide ↗
Virtus Investment Advisers, LLC
· CIK 0000019481| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 161 | STOK | STOKE THERAPEUTICS INC | Healthcare | 8,418.0 | $274K | 0.08% | +204.0 | +2.5% | $32.56 | +0.9% |
| 162 | RCUS | ARCUS BIOSCIENCES INC | Healthcare | 12,664.0 | $274K | 0.07% | +308.0 | +2.5% | $21.60 | +40.8% |
| 163 | MBX | MBX BIOSCIENCES INC | Healthcare | 9,131.0 | $273K | 0.07% | +221.0 | +2.5% | $29.85 | +126.3% |
| 164 | — | ZYMEWORKS INC | — | 10,702.0 | $268K | 0.07% | +261.0 | +2.5% | $25.04 | — |
| 165 | IRWD | IRONWOOD PHARMACEUTICALS INC | Healthcare | 76,169.0 | $267K | 0.07% | +2K | +2.5% | $3.51 | +23.5% |
| 166 | IMTX | IMMATICS N.V | Healthcare | 27,159.0 | $267K | 0.07% | +662.0 | +2.5% | $9.84 | -8.0% |
| 167 | IDYA | IDEAYA BIOSCIENCES INC | Healthcare | 8,014.0 | $267K | 0.07% | +195.0 | +2.5% | $33.32 | +16.5% |
| 168 | NUVL | NUVALENT INC | Healthcare | 2,602.0 | $267K | 0.07% | +64.0 | +2.5% | $102.45 | +21.0% |
| 169 | MGTX | MEIRAGTX HLDGS PLC | Healthcare | 30,570.0 | $265K | 0.07% | +746.0 | +2.5% | $8.66 | +69.4% |
| 170 | ABCL | ABCELLERA BIOLOGICS INC | Healthcare | 75,327.0 | $263K | 0.07% | +2K | +2.5% | $3.49 | +237.4% |
| 171 | NGNE | NEUROGENE INC | Healthcare | 13,033.0 | $263K | 0.07% | +317.0 | +2.5% | $20.16 | +92.2% |
| 172 | ABUS | ARBUTUS BIOPHARMA CORP | Healthcare | 57,895.0 | $261K | 0.07% | +1K | +2.5% | $4.50 | +10.1% |
| 173 | SEPN | SEPTERNA INC | Healthcare | 10,719.0 | $258K | 0.07% | +262.0 | +2.5% | $24.03 | +82.3% |
| 174 | AVBP | ARRIVENT BIOPHARMA INC | Healthcare | 11,165.0 | $258K | 0.07% | +271.0 | +2.5% | $23.07 | +28.5% |
| 175 | DYN | DYNE THERAPEUTICS INC | Healthcare | 14,150.0 | $257K | 0.07% | +344.0 | +2.5% | $18.13 | +45.7% |
| 176 | IMVT | IMMUNOVANT INC | Healthcare | 10,320.0 | $256K | 0.07% | +251.0 | +2.5% | $24.84 | +79.7% |
| 177 | PRTA | PROTHENA CORP PLC | Healthcare | 26,320.0 | $256K | 0.07% | +641.0 | +2.5% | $9.72 | -6.1% |
| 178 | JBIO | JADE BIOSCIENCES INC | Healthcare | 18,203.0 | $256K | 0.07% | +444.0 | +2.5% | $14.05 | +61.4% |
| 179 | SION | SIONNA THERAPEUTICS INC | Healthcare | 6,374.0 | $256K | 0.07% | +154.0 | +2.5% | $40.09 | -84.8% |
| 180 | KYMR | KYMERA THERAPEUTICS INC | Healthcare | 3,040.0 | $253K | 0.07% | +74.0 | +2.5% | $83.29 | +50.0% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
30.6%
Financial Services
23.4%
Industrials
11.2%
Technology
10.7%
Consumer Cyclical
7.6%
Energy
3.4%
Basic Materials
3.4%
Communication Services
3.1%
Consumer Defensive
2.9%
Real Estate
2.2%